Cargando…
Integrated omics and gene expression analysis identifies the loss of metabolite–metabolite correlations in small cell lung cancer
BACKGROUND AND OBJECTIVE: Small cell lung cancer (SCLC) is the most aggressive type of lung carcinoma with high metastatic potential and chemoresistance upon relapse. Cancer cells remodel the existing metabolic pathways for their benefits and the perturbations in cellular metabolism are the hallmark...
Autores principales: | Yu, Li, Li, Kefeng, Xu, Zhaoguo, Cui, Guoyuan, Zhang, Xiaoye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039056/ https://www.ncbi.nlm.nih.gov/pubmed/30013371 http://dx.doi.org/10.2147/OTT.S166149 |
Ejemplares similares
-
BTLA Expression in Stage I–III Non–Small-Cell Lung Cancer and Its Correlation with PD-1/PD-L1 and Clinical Outcomes
por: Li, Xiangmin, et al.
Publicado: (2020) -
Psychogenic fever in a patient with small cell lung cancer: a case report
por: Xu, Mengdan, et al.
Publicado: (2015) -
Multi-omic analyses identify mucosa bacteria and fecal metabolites associated with weight loss after fecal microbiota transplantation
por: Zhang, Fen, et al.
Publicado: (2022) -
Survival analysis with regard to PD-L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors
por: Xu, Yaolin, et al.
Publicado: (2019) -
Integrated Omic Analysis of Human Plasma Metabolites and Microbiota in a Hypertension Cohort
por: Chen, Bo-Yan, et al.
Publicado: (2023)